nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—P2RY12—forebrain—attention deficit hyperactivity disorder	0.0562	0.111	CbGeAlD
Treprostinil—P2RY12—cardiovascular system—attention deficit hyperactivity disorder	0.0475	0.0939	CbGeAlD
Treprostinil—PPARD—forebrain—attention deficit hyperactivity disorder	0.0467	0.0923	CbGeAlD
Treprostinil—PTGIR—forebrain—attention deficit hyperactivity disorder	0.0358	0.0709	CbGeAlD
Treprostinil—PPARD—midbrain—attention deficit hyperactivity disorder	0.0308	0.061	CbGeAlD
Treprostinil—P2RY12—nervous system—attention deficit hyperactivity disorder	0.0305	0.0603	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—attention deficit hyperactivity disorder	0.0303	0.0599	CbGeAlD
Treprostinil—P2RY12—central nervous system—attention deficit hyperactivity disorder	0.0294	0.0581	CbGeAlD
Treprostinil—PPARD—nervous system—attention deficit hyperactivity disorder	0.0253	0.0501	CbGeAlD
Treprostinil—PPARD—central nervous system—attention deficit hyperactivity disorder	0.0244	0.0482	CbGeAlD
Treprostinil—PPARD—cerebellum—attention deficit hyperactivity disorder	0.0239	0.0472	CbGeAlD
Treprostinil—P2RY12—brain—attention deficit hyperactivity disorder	0.0233	0.0461	CbGeAlD
Treprostinil—PTGIR—nervous system—attention deficit hyperactivity disorder	0.0195	0.0385	CbGeAlD
Treprostinil—PPARD—brain—attention deficit hyperactivity disorder	0.0194	0.0383	CbGeAlD
Treprostinil—PTGIR—central nervous system—attention deficit hyperactivity disorder	0.0187	0.037	CbGeAlD
Treprostinil—PTGIR—cerebellum—attention deficit hyperactivity disorder	0.0183	0.0362	CbGeAlD
Treprostinil—PTGIR—brain—attention deficit hyperactivity disorder	0.0149	0.0294	CbGeAlD
Treprostinil—PTGIR—G alpha (s) signalling events—DRD5—attention deficit hyperactivity disorder	0.0126	0.0256	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—GRM7—attention deficit hyperactivity disorder	0.0125	0.0254	CbGpPWpGaD
Treprostinil—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.0108	0.0214	CbGeAlD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ADRA2C—attention deficit hyperactivity disorder	0.00884	0.0179	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—ADRA2C—attention deficit hyperactivity disorder	0.00841	0.017	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00781	0.0158	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00765	0.0155	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00759	0.0154	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.00718	0.0145	CbGpPWpGaD
Treprostinil—PTGIR—G alpha (s) signalling events—DRD1—attention deficit hyperactivity disorder	0.00712	0.0144	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00704	0.0142	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00699	0.0141	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00686	0.0139	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00669	0.0135	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00655	0.0133	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00616	0.0125	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00612	0.0124	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00603	0.0122	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—HRH3—attention deficit hyperactivity disorder	0.00571	0.0116	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0053	0.0107	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00509	0.0103	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.00499	0.0101	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00499	0.0101	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.00488	0.00987	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00469	0.00949	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—ADRA2A—attention deficit hyperactivity disorder	0.00464	0.00939	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00463	0.00938	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00459	0.00929	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00455	0.00922	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00454	0.00919	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.0045	0.0091	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00442	0.00894	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00436	0.00883	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00431	0.00872	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00429	0.00868	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00426	0.00863	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ADRA2C—attention deficit hyperactivity disorder	0.00419	0.00848	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00418	0.00846	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00417	0.00844	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0041	0.0083	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00407	0.00823	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00405	0.0082	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00397	0.00803	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00396	0.00802	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00395	0.00799	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.0039	0.00789	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00384	0.00777	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00377	0.00764	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00377	0.00764	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00373	0.00754	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00369	0.00747	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00365	0.00739	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00359	0.00726	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00357	0.00723	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00351	0.00711	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00347	0.00703	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00347	0.00702	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00346	0.007	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.0034	0.00687	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00329	0.00666	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00323	0.00654	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00323	0.00654	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00319	0.00646	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00318	0.00644	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00302	0.00612	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00298	0.00602	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—EP300—attention deficit hyperactivity disorder	0.00297	0.00601	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00288	0.00582	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00282	0.00571	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00281	0.00569	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00278	0.00563	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00272	0.00551	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00268	0.00541	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00265	0.00536	CbGpPWpGaD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00264	0.00535	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00264	0.00535	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00261	0.00529	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.0026	0.00525	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00259	0.00523	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00256	0.00518	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00251	0.00507	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00246	0.00498	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00246	0.00498	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00243	0.00492	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00243	0.00492	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00241	0.00487	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.00239	0.00484	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00236	0.00477	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.0023	0.00466	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00227	0.00458	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00226	0.00458	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—ADRA2A—attention deficit hyperactivity disorder	0.0022	0.00446	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00212	0.00429	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—POLR3A—attention deficit hyperactivity disorder	0.00212	0.00428	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00208	0.00422	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00195	0.00396	CbGpPWpGaD
Treprostinil—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.00189	0.00382	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00187	0.00378	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0018	0.00364	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0018	0.00364	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00178	0.00359	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00172	0.00349	CbGpPWpGaD
Treprostinil—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00172	0.00347	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00171	0.00346	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00165	0.00335	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00163	0.00331	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00159	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00159	0.00321	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00157	0.00318	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00155	0.00314	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00154	0.00312	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00154	0.00311	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00151	0.00306	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00151	0.00306	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00149	0.00302	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00148	0.003	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00146	0.00296	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00144	0.00292	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00143	0.00289	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00142	0.00288	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00142	0.00286	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0014	0.00283	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00139	0.00282	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00139	0.00282	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00139	0.00282	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00137	0.00278	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00137	0.00278	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00137	0.00276	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00136	0.00274	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00133	0.00269	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00129	0.00261	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00129	0.00261	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00129	0.0026	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00128	0.00259	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00127	0.00256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00256	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00126	0.00256	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00125	0.00253	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00118	0.00238	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00116	0.00235	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00105	0.00212	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00103	0.00208	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00098	0.00198	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000974	0.00197	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000965	0.00195	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000917	0.00186	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000917	0.00185	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000911	0.00184	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000905	0.00183	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000897	0.00181	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000885	0.00179	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000852	0.00172	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000843	0.00171	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000825	0.00167	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000817	0.00165	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000814	0.00165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000811	0.00164	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000801	0.00162	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000784	0.00159	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—COMT—attention deficit hyperactivity disorder	0.00078	0.00158	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000775	0.00157	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000759	0.00154	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—EP300—attention deficit hyperactivity disorder	0.000752	0.00152	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000751	0.00152	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000746	0.00151	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000746	0.00151	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000737	0.00149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000687	0.00139	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000523	0.00106	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000481	0.000973	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000375	0.000759	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—EP300—attention deficit hyperactivity disorder	0.000335	0.000677	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000277	0.00056	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000259	0.000524	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000259	0.000524	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000255	0.000516	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000255	0.000516	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000237	0.000479	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000207	0.000419	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000197	0.000399	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000157	0.000318	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000156	0.000315	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000151	0.000306	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	6.73e-05	0.000136	CbGpPWpGaD
